When biologist Igor Luchini Baptista first posed a simple question in his lab at the State University of Campinas in São Paulo, Brazil, he didn't expect to stumble onto something that could change how patients recover from liver surgery. "If HMB is produced in the liver, why has almost no one investigated its direct effect on that organ?" he asked. The answer, published in March in the journal Acta Physiologica, suggests that taking a supplement for just ten days before going under the knife may help the liver not just recover, but recover better.
The research centered on beta-hydroxy-beta-methylbutyrate (HMB), a metabolite derived from leucine, an essential amino acid found in foods like meat and dairy. Only about 5% of ingested leucine gets converted into HMB, primarily in the liver, which is why supplementation has become popular for purposes like preserving muscle mass during aging or illness recovery. But Baptista and his team at UNICAMP's Faculty of Applied Sciences in Limeira wondered whether the compound might offer direct benefits to the organ where it's made.
Working with an experimental mouse model, the researchers gave animals a daily dose of HMB equivalent to what a 70-kilogram adult would take—roughly 3 grams per day—for ten days before performing a hepatectomy, a procedure in which approximately 70% of the liver is removed. (This resection volume is a classic model for studying liver regeneration.) At the time of surgery, supplementation stopped.
The results were striking not because livers regrew faster—after all, the liver is already remarkable at restoring itself, with all mice recovering their liver mass in about seven days—but because of the quality of that recovery. Seven days after the initial surgery, Baptista's team exposed the mice to a second injury: a high dose of acetaminophen, a standard model for simulating liver toxicity. The mice that had received HMB beforehand showed markedly fewer signs of damage, maintained better mitochondrial function, and displayed more appropriate signs of cellular regeneration. Their livers, in essence, were better equipped to handle a new challenge.
"We didn't see faster regeneration, but higher-quality regeneration," Baptista explained. "That liver seems better prepared to handle a new challenge."
The study's design proved crucial. In an initial phase, some molecular markers hinted at a more favorable profile in supplemented animals, but the differences weren't dramatic. It was only by introducing a second stressor that the researchers could clearly reveal how fundamentally different the outcomes were between groups. Mice that hadn't received HMB showed more tissue damage, cellular distress, and structural changes alongside poorer metabolic performance.
The implications for human medicine are still being mapped. Baptista is careful to note that robust clinical studies in humans remain limited. "It's a supplement that's already widely used outside the gym, but the described effects, especially on muscle, are still subtle," he said. "We still lack good clinical studies to support its broader use."
Still, the findings offer a compelling avenue for exploration. Liver surgery, whether for tumor removal, donation, or trauma, carries real risks of complications during recovery. If something as straightforward as a ten-day preoperative supplement could improve organ resilience, it would represent a simple, low-cost intervention with meaningful impact. The next step will be translating these mouse findings into human trials—a journey that typically takes years, but one that now has a clear direction.
For now, Baptista's simple question has opened a door. What happens before the scalpel matters as much as what happens after.